Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Pradaxa Bleeding Litigation
The Firm is evaluating Pradaxa side effect lawsuits on behalf of individuals who have suffered episodes of life-threatening internal bleeding, allegedly due to their use of the blood thinner.
New York, NY (PRWEB) September 12, 2013
Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) filed on behalf of patients who suffered serious and life-threatening episodes of internal bleeding while taking the blood thinner are moving forward in the federal multidistrict litigation now underway in U.S. District Court, Southern District of Illinois. According to a Case Management Order issued by the Court on September 7, 2013, a Special Master has been appointed to mediate any disputes that may occur in the course of discovery. The Order also sets forth protocols for the mediation of such disputes. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“Alleged victims of Pradaxa bleeding contact our Firm on a regular basis. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating Pradaxa side effect lawsuits on behalf of patients who suffered serious internal bleeding while using this blood thinner.
Pradaxa Bleeding Lawsuits
According to court documents, 1,488 Pradaxa side effect claims have been filed in the Southern District of Illinois on behalf of alleged victims of Pradaxa bleeding. The lawsuits filed in the litigation accuse Boehringer Ingelheim of marketing Pradaxa even though it was aware that the drug could cause dangerous and potentially fatal hemorrhaging in some patients. Plaintiffs further allege that the company failed to provide adequate warnings regarding the lack of a readily available antidote to reverse the bleeding that can sometimes occur with Pradaxa.
Bloomberg.com reported in December 2012 that Pradaxa has been the subject of regulatory warnings in several countries, due to its association with internal bleeding, a known Pradaxa side effect. While it was touted as an improvement over warfarin, there is currently no easy way to stop internal bleeding should it occur in Pradaxa patients. By contrast, warfarin bleeding can be staunched with the administration of vitamin K.* According to the Institute for Safe Medicine Practices (ISMP), an analysis of hemorrhage cases reported to the U.S. Food & Drug Administration during the second quarter of 2012 found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.
Patients who allegedly suffered life-threating Pradaxa bleeding may be eligible to file a lawsuit seeking compensation for medical bills, lost wages, pain and suffering and other damages. Learn More about alleged Pradaxa bleeding at Bernstein Liebhard LLP’s website. Free and no obligation legal reviews can be obtained by calling 800-511-5092.
*bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
For the original version on PRWeb visit: http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb11118274.htm